This page shows the latest New Zealand news and features for those working in and with pharma, biotech and healthcare.
The treatment is currently licensed in more than 100 countries globally, including all European countries, Australia, New Zealand and Canada, with a roll-out of over 800 million doses to date.
VLA2001 has a busy development programme including a trial in older people currently underway in New Zealand, an expansion of Cov-Compare trial in adolescents, a new trial looking at children
The trial for VLA2001 will involve people over the age of 56 in New Zealand and aims to generate additional safety and immunogenicity data in older people. ... The French biotech’s new trial (VLA2001-304) will also test VLA2001 and a second vaccine
The patient population included participants of mixed ethnicities in the UK, Ireland, Australia, the US, the Netherlands, New Zealand, Canada and France.
The new license agreement grants Merck the right to develop additional multispecific antibody candidates using Zymework’s Azymetric and EFECT platforms. ... Chinese pharma BeiGene also owns the rights to Zanidatamab and ZW49 in a number of East Asian
Given that the pharma industry is prevented from advertising directly to consumers almost everywhere (except the USA and New Zealand), being able to provide support to medication users via voice tech ... task with limited added value, especially when the
More from news
Approximately 3 fully matching, plus 70 partially matching documents found.
The TPP covers 11 pacific trading nations, including Australia, New Zealand, Canada and Malaysia, valued at 13% of the global economy and more than £110bn of trade in 2019. ... With this in mind, the UK’s importance in the development of new chemical
The House of Commons has called for new independent regulation to be funded by a levy on tech companies operating in the UK, in order “.to create a regulatory system for ... prescription-only medicines is illegal outside the United States or New Zealand
and New Zealand.
635. Zealand Pharma/ Boehringer Ingelheim. R&D collaboration. Peptide discovery collaboration with cardio-metabolic focus. ... 12. All deals are worldwide unless otherwise noted. Europe, Japan, Canada, Australia and New Zealand.
prohibit Cosmo from competing directly with the new company in the gastrointestinal area in the US. ... In 2014, under this new agreement, Zealand expects to receive payments from its partner of around $7.5m.
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
She has a BSc and a MBChB gained from the University of Otago, New Zealand. ... After graduating, Sykes worked in hospitals in the Auckland region of New Zealand for three years across a range of medical specialities.
He also brings management experience from Sanofi's operations in the US, Thailand, New Zealand and Australia to the role. ... Luke will bring a strong new voice to the decisions and choices we will have to make for our pharmaceuticals business.
based role as managing director of MSD Australia and New Zealand. ... She will officially take on her new role on 1 February, when Quodt moves to a new European level position.
Britt Meelby Jensen joins from cancer diagnostics firm Dako. Denmark-based Zealand Pharma has appointed Britt Meelby Jensen as its new CEO, effective from January 15, 2015. ... Regarding his departure from the company, Solomon said: "Zealand is entering
Aki von Roy will be based in Auckland, New Zealand. Oxford, UK-headquartered advisory firm PharmaVentures has appointed Aki von Roy as an associate based in Auckland, New Zealand.
More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.
As we celebrate AMICULUM’s 20th year, we’re delighted to welcome a new full-service agency to the family, one that continues our ambition to respond to the rapidly changing ... About AMICULUM. AMICULUM ( www.amiculum.biz) is an independent global
The launch of Cence has created several new opportunities for talented individuals to join the team, including a new vacancy for an account executive. ... About AMICULUM. AMICULUM ( www.amiculum.biz) is an independent global healthcare communications,
We can learn from other countries such as New Zealand which is a prime example. ... New Zealand is a country with lower pollution, more green space and lower levels of health inequalities that has adopted green prescribing with successful patient
Scott Arrol, Chief Executive Officer at New Zealand Health IT, discusses the roles of interoperability, connected health, and digital identity in enabling a healthier population. ... health adoption in New Zealand and internationally.
She graduated from the University of Otago, New Zealand, with a BSc in pharmacology and an MBChB.
More from PMHub
Approximately 1 fully matching, plus 17 partially matching documents found.
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...